Stocks · News reference
Pomdoctor To Terminate Its ADR Program And List Its Class A Ordinary Shares Directly On The Nasdaq
The termination was previously approved by the board of directors of Pomdoctor on September 3, 2026 and approved by the Company's shareholders on a non-binding advisory basis at the extraordinary general meeting of
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
POMDOCTOR shares are trading higher after the company announced plans to terminate its ADR program and directly list its Class A ordinary shares on the Nasdaq.
Pomdoctor In Nasdaq’s Delisting List
The company has been targeted in an aggressive two-year-old campaign to delist suspicious Chinese companies from Wall Street image credit: Bamboo Works Key Takeaways: Here today, gone tomorrow. That